Docetaxel-based chemotherapy trials in androgen-independent prostate cancer: first demonstration of a survival benefit.
Petrylak
Daniel P
DP
Department of Medicine, Division of Medical Oncology, College of Physicians and Surgeons, Columbia-Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA. dpp5@columbia.edu